Twist Bioscience Corp
TWST
Market Cap$1.89B
Close$
$42.26
49% upside
Current Fair Value
49% upsideUndervalued by 49% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.89 Billion |
|---|---|
| Enterprise Value | $1.58 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.6 |
| Beta | 2.89 |
| Outstanding Shares | 57,818,022 |
| Avg 30 Day Volume | 706,950 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.18 |
|---|---|
| PEG | -324.32 |
| Price to Sales | 7.09 |
| Price to Book Ratio | 2.84 |
| Enterprise Value to Revenue | 6.02 |
| Enterprise Value to EBIT | -7.69 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Twist Bioscience Corp
CEO: Emily Leproust Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...